6. Ongoing R&D and Trials
non-invasive,
easy to use
experience
Accurate &
Reliable
Novel
technologies
Medical
clearance
AI powered
combination
of 4 optical
and electrical
methods
A pre-trial on
50 patients
with ~83%
accuracy.
Ongoing
US-patent
process
Collaboration
with EMRI for
further trials.
12. Facilities and location Research Human resource Production Trials/IP/Clearance
10%
30%
50%
5% 5%
750m Tomans for 3 years
Investing
13. Contact
Website: www.ako.technology
Current address: Jalal Al Ahmad highway, Endocrinology and Metabolism Research Center, Tehran, Iran.
Tel: +989108431815, +989353917352
Instagram: akosmarttechnologies
LinkedIn: https://www.linkedin.com/company/ako-smart-technologies-group/
Twitter: https://twitter.com/AkoTechnologies
Thanks for attention.
Editor's Notes
I am Hamed Ghodsi and I am glad to present for AKO smart technologies group.
We are proud to be AKO team together since November 2015.
How many diabetics do you guess exist all over the world?
422m!!!
What is this number about Iran?
More than 6m
And it is getting worse
Because
54% of men and 74 percent of young women and at risk
How many diabetics do you guess exist all over the world?
422m!!!
What is this number about Iran?
More than 6m
And it is getting worse
Because
54% of men and 74 percent of young women and at risk
How many diabetics do you guess exist all over the world?
422m!!!
What is this number about Iran?
More than 6m
And it is getting worse
Because
54% of men and 74 percent of young women and at risk
How many diabetics do you guess exist all over the world?
422m!!!
What is this number about Iran?
More than 6m
And it is getting worse
Because
54% of men and 74 percent of young women and at risk
During last 3 years we have worked hard on converting the initial theoretical idea to a real world device which is now up and running for doing tests in the Iran diabetes clinic .
After an initial medical trial on about 50 patients which results in a significant correlation with laboratory results no we should design more advanced standard trials for passing the medical regulations
In the mean time we will design and launch the final product into the market in the next year as I believe.
There are also more steps for the future, for instance development of AI powered platform and big data analysis.
As mentioned before there is a wide market
About ( point to the slide) 422m potential users worldwide
About 15m potential users in Iran
And target entry market in Iran about 1% of total Iran’s market equal to 1.5 people
Development of diabetes monitoring devices is an interesting research field in both academic and commercial research centers since last century ( as I know )
But in the recent years the focus is on minimally invasive and truly non-invasive methods
Noninvasive methods are still under development for instance
Sugar beat and Glucowise
However minimally invasive devices have been commercialized in last 2years.
For instance
Medtronic guardian device and freestyle libre
In addition the tech companies working on wearable technologies and devices like Apple and Helo are also working on noninvasive devices.
Development of diabetes monitoring devices is an interesting research field in both academic and commercial research centers since last century ( as I know )
But in the recent years the focus is on minimally invasive and truly non-invasive methods
Noninvasive methods are still under development for instance
Sugar beat and Glucowise
However minimally invasive devices have been commercialized in last 2years.
For instance
Medtronic guardian device and freestyle libre
In addition the tech companies working on wearable technologies and devices like Apple and Helo are also working on noninvasive devices.
We need 300,000 USD seed investment for our pre launch plan mainly for completing the trials and passing the regulations and also producing the final product in a costumer ready size and design
We need 300,000 USD seed investment for our pre launch plan mainly for completing the trials and passing the regulations and also producing the final product in a costumer ready size and design